Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 38.0539.68---

What is the latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA is 38.05 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202538.05
Mar202439.68
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of MANKIND PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 38.05
-4.11
Mar2024 39.68
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of MANKIND PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹89,953.2 Cr -1.2% -2.6% -16.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,170.0 Cr -1.6% 4.6% -0.8% Stock Analytics
DIVIS LABORATORIES ₹167,038.0 Cr -2.5% -6% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,357.0 Cr 1.2% -1.4% 11.8% Stock Analytics
CIPLA ₹120,414.0 Cr -1.2% -1.5% -0.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,015.0 Cr -2.7% 4% 2.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.2%

-2.6%

-16.6%

SENSEX

-0.6%

1.7%

4.6%


You may also like the below Video Courses